210 related articles for article (PubMed ID: 1699417)
1. Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.
Macri JN; Kasturi RV; Krantz DA; Cook EJ; Moore ND; Young JA; Romero K; Larsen JW
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1248-53. PubMed ID: 1699417
[TBL] [Abstract][Full Text] [Related]
2. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
[TBL] [Abstract][Full Text] [Related]
3. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A.
Spencer K; Aitken DA; Crossley JA; McCaw G; Berry E; Anderson R; Connor JM; Macri JN
Ann Clin Biochem; 1994 Sep; 31 ( Pt 5)():447-54. PubMed ID: 7530437
[TBL] [Abstract][Full Text] [Related]
4. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
Wenstrom KD; Owen J; Chu DC; Boots L
Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
Milunsky A; Nebiolo LM; Bellet D
Fetal Diagn Ther; 1993; 8(4):221-4. PubMed ID: 7505085
[TBL] [Abstract][Full Text] [Related]
7. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
Macri JN; Spencer K; Garver K; Buchanan PD; Say B; Carpenter NJ; Muller F; Boué A
Prenat Diagn; 1994 Feb; 14(2):97-103. PubMed ID: 7514291
[TBL] [Abstract][Full Text] [Related]
9. Free beta-chorionic gonadotropin: a cross-reactivity study of two immunometric assays used in prenatal maternal serum screening for Down's syndrome.
Macri JN; Spencer K; Anderson RW; Cook EJ
Ann Clin Biochem; 1993 Jan; 30 ( Pt 1)():94-8. PubMed ID: 7679563
[TBL] [Abstract][Full Text] [Related]
10. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
Spencer K; Coombes EJ; Mallard AS; Ward AM
Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():506-18. PubMed ID: 1280026
[TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for trisomy 18 with free beta human chorionic gonadotrophin as a marker.
Spencer K; Mallard AS; Coombes EJ; Macri JN
BMJ; 1993 Dec; 307(6917):1455-8. PubMed ID: 7506599
[TBL] [Abstract][Full Text] [Related]
12. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results.
Cheng PJ; Chu DC; Chueh HY; See LC; Chang HC; Weng DR
Am J Obstet Gynecol; 2004 Feb; 190(2):442-7. PubMed ID: 14981387
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald NJ; Densem JW
Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum screening for Down syndrome before 15 weeks.
Cuckle H; Lilford R; Jones R
Am J Obstet Gynecol; 1994 Mar; 170(3):959. PubMed ID: 7511335
[No Abstract] [Full Text] [Related]
15. Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
Wenstrom KD; Owen J; Chu Dc; Boots L
Am J Obstet Gynecol; 1999 Oct; 181(4):887-92. PubMed ID: 10521748
[TBL] [Abstract][Full Text] [Related]
16. The influence of gravidity on Down's syndrome screening with free beta hCG.
Spencer K
Prenat Diagn; 1995 Jan; 15(1):87-9. PubMed ID: 7537879
[TBL] [Abstract][Full Text] [Related]
17. Serum screening for Down's syndrome.
Bibby J; McCormack MJ
Br J Obstet Gynaecol; 1994 Jun; 101(6):557-8. PubMed ID: 7517183
[No Abstract] [Full Text] [Related]
18. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
19. First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
Krantz DA; Larsen JW; Buchanan PD; Macri JN
Am J Obstet Gynecol; 1996 Feb; 174(2):612-6. PubMed ID: 8623793
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
Greenberg F; Schmidt D; Darnule AT; Weyland BR; Rose E; Alpert E
Am J Obstet Gynecol; 1992 May; 166(5):1388-92. PubMed ID: 1375811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
